HomeCompareTCHBF vs EPRT

TCHBF vs EPRT: Dividend Comparison 2026

TCHBF yields 2.40% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPRT wins by $5.7K in total portfolio value
10 years
TCHBF
TCHBF
● Live price
2.40%
Share price
$156.30
Annual div
$3.75
5Y div CAGR
36.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$12,459.60
Full TCHBF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — TCHBF vs EPRT

📍 EPRT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCHBFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCHBF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCHBF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCHBF
Annual income on $10K today (after 15% tax)
$203.76/yr
After 10yr DRIP, annual income (after tax)
$10,590.66/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EPRT beats the other by $323.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCHBF + EPRT for your $10,000?

TCHBF: 50%EPRT: 50%
100% EPRT50/50100% TCHBF
Portfolio after 10yr
$60.5K
Annual income
$12,650.16/yr
Blended yield
20.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

TCHBF
No analyst data
Altman Z
4.2
Piotroski
4/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCHBF buys
0
EPRT buys
0
No recent congressional trades found for TCHBF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCHBFEPRT
Forward yield2.40%3.92%
Annual dividend / share$3.75$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR36.6%29%
Portfolio after 10y$57.7K$63.4K
Annual income after 10y$12,459.60$12,840.73
Total dividends collected$33.5K$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TCHBF vs EPRT ($10,000, DRIP)

YearTCHBF PortfolioTCHBF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$11,027$327.45$11,205$505.18$178.00EPRT
2$12,260$460.98$12,672$682.46$412.00EPRT
3$13,773$654.30$14,490$930.48$717.00EPRT
4$15,675$938.36$16,786$1,282.69$1.1KEPRT
5$18,136$1,363.41$19,753$1,791.56$1.6KEPRT
6$21,419$2,013.82$23,677$2,541.64$2.3KEPRT
7$25,955$3,036.35$29,008$3,672.99$3.1KEPRT
8$32,469$4,697.14$36,463$5,425.08$4.0KEPRT
9$42,243$7,501.50$47,238$8,221.57$5.0KEPRT
10$57,660$12,459.60$63,385$12,840.73$5.7KEPRT

TCHBF vs EPRT: Complete Analysis 2026

TCHBFStock

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

Full TCHBF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this TCHBF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCHBF vs SCHDTCHBF vs JEPITCHBF vs OTCHBF vs KOTCHBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.